Seda Iberica Awarded Great Place to Work Certification!
Seda Iberica announces it has been awarded Great Place to Work Certification at first attempt.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241118173108/en/
The Seda Iberica team celebrates the Great Place to Work! (Photo: Business Wire)
This prestigious certification by the global authority on workplace culture recognises Seda’s success in building an inclusive workplace that unlocks high levels of team collaboration, innovation and financial performance.
Announcing the news, Seda Iberica Managing Director Anselmo Vilardebo said: “We are very proud of this fantastic result. With 71% of our colleagues finding Seda a Great Place to Work, it confirms the quality of our management team’s work and shows how we live Seda’s mission, values and ethics.”
The confidential survey of all Seda Iberica employees gave very high scores for Safety, Diversity and Inclusion, Sense of Community and Sense of Value, with a massive 86% of respondents stating “When I look at what we accomplish, I feel a sense of pride” and 91% agreeing “I feel good about the ways we contribute to the community”.
Seda Iberica HR Director Daniela Fernandes observed: “This GPTW certification is a fantastic collective achievement that reflects our colleagues’ strong belief in our strengths and determination to improve together.”
Seda Group HR Director Giovanni De Liso explained: "This important milestone confirms Seda’s ability to involve all its people in continuous improvement, with 78% of team members choosing to participate and bring us an enhanced awareness of our strengths and areas for growth.”
Seda Group CEO Antonio D’Amato commented: “Our people are our most precious asset. So we’re delighted with this new confirmation that they feel valued and supported to give their best. Providing paradigm-changing scientific, technological and design innovations, they make a significant difference for our customers, communities and planet.”
Seda Group COO Gianfranco D’Amato added: “We’re very pleased with this new achievement, Seda’s third Great Place to work Certification in 2024! It’s another high-score result at first attempt, following the first-time certification of Seda UK and recertification of Seda North America. We look forward to further extending the initiative across the rest of the Group.”
Seda Iberica is part of Seda International, a leading food and food service packaging group that develops and supplies unique, innovative sustainable packaging solutions. Seda is headquartered in Italy with manufacturing platforms in Italy, Germany, Portugal, UK and North America.
You can read Seda’s Great Place to Work Certification report at Seda International Packaging Group | Great Place To Work® Portugal
Discover more about Seda at www.sedagroup.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241118173108/en/
Contacts
For media enquiries, contact:
Simone Ceruti
Group Director Comms and External Affairs
Simone_ceruti@sedagorup.com
Mobile + 39 3459976498
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press Release
Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of the EIOS:VSE stock reflects this strength: Price per Share (PPS): +132% in the first half (H1) of 2025, stabilizing at a +116% YTD increase. Daily Trading Volume: peaks of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press Release
500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to strengthen Morocco’s innovation and digital competitiveness by accelerating high-potential founders and providing the training and financing pa
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press Release
Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218764112/en/ Image courtesy of Neural Concept (L-R clockwise from top) Jonathan Donier, CSO & Co-founder; Thomas von Tschammer, Managing Director US & Co-founder; Théophile Allard, CTO & Co-founder; Pierre Baqué CEO & Co-founder; Philippe Cuendet, COO Neural Concept is redefining engineering workflows with CAD-native enterprise AI that understands geometry, constraints and design intent. By helping its customers build and deploy physics-aware design copilots, the platform enables teams to explore millions of design options earlier and avoid costly la
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press Release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special? MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom